Glaxosmithkline Consumer Healthcare Holdings DBA Haleon
Glaxosmithkline Consumer Healthcare Holdings DBA Haleon appears in FDA public data with 3 recalls — including 3 Class I (most serious) —, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0183-2023, Class I) was initiated on December 6, 2022.
Summary
- Total Recalls
- 3 (3 Class I)
- 510(k) Clearances
- 0
- Inspections
- 0
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0183-2023 | Class I | Advil Liqui Gels (minis), Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever Reducer (NSAID) | December 6, 2022 |
| D-0182-2023 | Class I | Advil Liqui Gels, Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever Reducer (NSAID), 200 li | December 6, 2022 |
| D-0181-2023 | Class I | Advil (ibuprofen) Tablets, 200 mg, packaged as a) 360-count bottles (UPC 3 0573 0154 60 4), and b) 2 | December 6, 2022 |